117 related articles for article (PubMed ID: 30181816)
1. Correction: Immunogenicity of mammary tumor cells can be induced by shikonin via direct binding-interference with hnRNPA1.
Yin SY; Efferth T; Jian FY; Chen YH; Liu CI; Wang AHJ; Chen YR; Hsiao PW; Yang NS
Oncotarget; 2018 Aug; 9(63):32271. PubMed ID: 30181816
[TBL] [Abstract][Full Text] [Related]
2. Correction: P-cadherin mutations are associated with high basal Wnt activity and stemness in canine mammary tumor cell lines.
Timmermans-Sprang E; Collin RWJ; Henkes A; Philipsen M; Mol JA
Oncotarget; 2020 Feb; 11(5):573. PubMed ID: 32082491
[TBL] [Abstract][Full Text] [Related]
3. Correction: Shikonin Suppresses NLRP3 and AIM2 Inflammasomes by Direct Inhibition of Caspase-1.
Zorman J; Sušjan P; Hafner-Bratkovič I
PLoS One; 2016; 11(9):e0163887. PubMed ID: 27657699
[TBL] [Abstract][Full Text] [Related]
4. Correction: 4-Hydroxyestradiol induces mammary epithelial cell transformation through Nrf2-mediated heme oxygenase-1 overexpression.
Park SA; Lee MH; Na HK; Surh YJ
Oncotarget; 2019 Feb; 10(12):1266. PubMed ID: 30815229
[TBL] [Abstract][Full Text] [Related]
5. Correction: Targeting a ribonucleoprotein complex containing the caprin-1 protein and the c-Myc mRNA suppresses tumor growth in mice: an identification of a novel oncotarget.
Qiu YQ; Yang CW; Lee YZ; Yang RB; Lee CH; Hsu HY; Chang CC; Lee SJ
Oncotarget; 2019 Aug; 10(47):4919. PubMed ID: 31448057
[TBL] [Abstract][Full Text] [Related]
6. Correction: CAPN1 is a novel binding partner and regulator of the tumor suppressor NF1 in melanoma.
Alon M; Arafeh R; Lee JS; Madan S; Kalaora S; Nagler A; Abgarian T; Greenberg P; Ruppin E; Samuels Y
Oncotarget; 2019 Feb; 10(13):1344. PubMed ID: 30863494
[TBL] [Abstract][Full Text] [Related]
7. Correction: Improved anti-tumor efficacy via combination of oxaliplatin and fibrin glue in colorectal cancer.
Hu Y; Yu T; Liu X; He Y; Deng L; Guo J; Hua Y; Luo T; Gao X
Oncotarget; 2020 Sep; 11(37):3484-3485. PubMed ID: 32973972
[TBL] [Abstract][Full Text] [Related]
8. Shikonin inhibits oxidized LDL-induced monocyte adhesion by suppressing NFκB activation via up-regulation of PI3K/Akt/Nrf2-dependent antioxidation in EA.hy926 endothelial cells.
Huang CS; Lin AH; Yang TC; Liu KL; Chen HW; Lii CK
Biochem Pharmacol; 2015 Feb; 93(3):352-61. PubMed ID: 25541286
[TBL] [Abstract][Full Text] [Related]
9. Correction: Sirt3-mediated mitophagy protects tumor cells against apoptosis under hypoxia.
Qiao A; Wang K; Yuan Y; Guan Y; Ren X; Li L; Chen X; Li F; Chen AF; Zhou J; Yang JM; Cheng Y
Oncotarget; 2018 Jun; 9(43):27318. PubMed ID: 29930768
[TBL] [Abstract][Full Text] [Related]
10. Correction: Tumor-associated macrophages promote tumor metastasis via the TGF-β/SOX9 axis in non-small cell lung cancer.
Zhang S; Che D; Yang F; Chi C; Meng H; Shen J; Qi L; Liu F; Lv L; Li Y; Meng Q; Liu J; Shang L; Yu Y
Oncotarget; 2020 Dec; 11(52):4845-4846. PubMed ID: 33447352
[TBL] [Abstract][Full Text] [Related]
11. Correction: Necrosis-inducing peptide has the beneficial effect on killing tumor cells through neuropilin (NRP-1) targeting.
Kim JY; Han JH; Park G; Seo YW; Yun CW; Lee BC; Bae J; Moon AR; Kim TH
Oncotarget; 2018 Jun; 9(42):26977. PubMed ID: 29928495
[TBL] [Abstract][Full Text] [Related]
12. Correction: Metabolic pathway for the universal fluorescent recognition of tumor cells.
Fernandez-Carrascal A; Garcia-Algar M; Nazarenus M; Torres-Nuñez A; Guerrini L; Feliu N; Parak WJ; Garcia-Rico E; Alvarez-Puebla RA
Oncotarget; 2019 Nov; 10(61):6643. PubMed ID: 31762944
[TBL] [Abstract][Full Text] [Related]
13. Correction: Co-targeting translation and proteasome rapidly kills colon cancer cells with mutant
Li X; Li M; Ruan H; Qiu W; Xu X; Lin Z; Yu J
Oncotarget; 2018 Jan; 9(6):7271. PubMed ID: 29467964
[TBL] [Abstract][Full Text] [Related]
14. Correction: Tumor-suppressive microRNA-218 inhibits tumor angiogenesis via targeting the mTOR component RICTOR in prostate cancer.
Guan B; Wu K; Zeng J; Xu S; Mu L; Gao Y; Wang K; Ma Z; Tian J; Shi Q; Guo P; Wang X; He D; Du Y
Oncotarget; 2022; 13():507. PubMed ID: 35284038
[TBL] [Abstract][Full Text] [Related]
15. Correction: Infiltrating mast cells increase prostate cancer chemotherapy and radiotherapy resistances via modulation of p38/p53/p21 and ATM signals.
Xie H; Li C; Dang Q; Chang LS; Li L
Oncotarget; 2019 Jun; 10(39):3978. PubMed ID: 31231473
[TBL] [Abstract][Full Text] [Related]
16. Correction: Regulation of tumor suppressor EAF2 polyubiquitination by ELL1 and SIAH2 in prostate cancer cells.
Yu X; Ai J; Cai L; Jing Y; Wang D; Dong J; Pascal LE; Zhang J; Luo R; Wang Z
Oncotarget; 2019 Dec; 10(67):7181-7182. PubMed ID: 31903175
[TBL] [Abstract][Full Text] [Related]
17. Correction: 6-Shogaol attenuates LPS-induced inflammation in BV2 microglia cells by activating PPAR-γ.
Han Q; Yuan Q; Xie G
Oncotarget; 2018 Jun; 9(44):27585. PubMed ID: 29938008
[TBL] [Abstract][Full Text] [Related]
18. Correction: Comparative oncology DNA sequencing of canine T cell lymphoma via human hotspot panel.
McDonald JT; Kritharis A; Beheshti A; Pilichowska M; Burgess K; Ricks-Santi L; McNiel E; London CA; Ravi D; Evens AM
Oncotarget; 2018 Sep; 9(70):33441. PubMed ID: 30279973
[TBL] [Abstract][Full Text] [Related]
19. Correction: Simultaneous delivery of olaparib and carboplatin in PEGylated liposomes imparts this drug combination hypersensitivity and selectivity for breast tumor cells.
Novohradsky V; Zajac J; Vrana O; Kasparkova J; Brabec V
Oncotarget; 2018 Oct; 9(85):35599. PubMed ID: 30473754
[TBL] [Abstract][Full Text] [Related]
20. Correction: Se
Zhang HN; Feng WL; An CN; Li WG
Oncotarget; 2018 Nov; 9(92):36542. PubMed ID: 30559936
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
